More people with HIV/AIDS are getting inexpensive anti-retroviral drugs and their life-expectancy has increased, but universal access is still far off, and the disease is still spreading, if more slowly than before. Progress has been made in reducing malaria and measles, and the rate of child mortality has fallen partly as a result, but the goal of a two-thirds reduction will not be met.